143 related articles for article (PubMed ID: 9458077)
1. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?
Cheng L; Shan A; Cheville JC; Qian J; Bostwick DG
Cancer Res; 1998 Feb; 58(3):389-91. PubMed ID: 9458077
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis).
Doll JA; Zhu X; Furman J; Kaleem Z; Torres C; Humphrey PA; Donis-Keller H
Am J Pathol; 1999 Sep; 155(3):967-71. PubMed ID: 10487854
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic changes and loss of heterozygosity in atypical adenomatous hyperplasia, in carcinoma of the prostate and in non-neoplastic prostate tissue using comparative genomic hybridization and multiplex-PCR.
Bettendorf O; Schmidt H; Eltze E; Gockel I; Semjonow A; Bürger H; Böcker W; Brandt B
Int J Oncol; 2005 Jan; 26(1):267-74. PubMed ID: 15586249
[TBL] [Abstract][Full Text] [Related]
4. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
Rekhi B; Jaswal TS; Arora B
Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
[TBL] [Abstract][Full Text] [Related]
5. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization.
Qian J; Jenkins RB; Bostwick DG
Urology; 1995 Dec; 46(6):837-42. PubMed ID: 7502426
[TBL] [Abstract][Full Text] [Related]
8. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
9. [Premalignant and benign lesions in nodules of adenomatous hyperplasia].
Miján Ortiz JL; Fernández Rodríguez A; Fernández Ruiz PL; de la Fuente Serrano A; Nogales Fernández F; Zuluaga Gómez A
Arch Esp Urol; 1996 Sep; 49(7):684-7. PubMed ID: 9020004
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia: it is a premalignant lesion?
Grignon D; Sakr W
In Vivo; 1994; 8(3):415-8. PubMed ID: 7528557
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
[TBL] [Abstract][Full Text] [Related]
12. Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype.
Lopez-Beltran A; Qian J; Montironi R; Luque RJ; Bostwick DG
Int J Surg Pathol; 2005 Apr; 13(2):167-73. PubMed ID: 15864380
[TBL] [Abstract][Full Text] [Related]
13. Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate.
Stamatiou K; Alevizos A; Natzar M; Mihas C; Mariolis A; Michalodimitrakis E; Sofras F
Asian J Androl; 2007 Mar; 9(2):229-33. PubMed ID: 16751999
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
[TBL] [Abstract][Full Text] [Related]
15. DNA fingerprint detection of somatic mutations in benign prostatic hyperplasia and prostatic adenocarcinoma.
Werely CJ; Heyns CF; Van Velden DJ; Van Helden PD
Genes Chromosomes Cancer; 1996 Sep; 17(1):31-6. PubMed ID: 8889504
[TBL] [Abstract][Full Text] [Related]
16. Nuclear volume estimates in prostatic atypical adenomatous hyperplasia.
López-Beltrán A; Artacho-Pérula E; Luque-Barona RJ; Roldán-Villalobos R
Anal Quant Cytol Histol; 2000 Dec; 22(6):438-44. PubMed ID: 11147297
[TBL] [Abstract][Full Text] [Related]
17. Preneoplastic lesions of the prostate-clinical, pathological and molecular biological aspects.
Nasir A; Copeland J; Gillespie JW; Chughtai OR; Andrawis R; Kaiser HE; Manyak MJ
In Vivo; 2002; 16(6):557-66. PubMed ID: 12494901
[TBL] [Abstract][Full Text] [Related]
18. Premalignant lesions of the prostate.
Bostwick DG
Semin Diagn Pathol; 1988 Aug; 5(3):240-53. PubMed ID: 3051237
[TBL] [Abstract][Full Text] [Related]
19. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
20. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
